Serina Therapeutics, Inc. financial data

Symbol
SER on NYSE
Location
Huntsville, AL
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 181% % 144%
Debt-to-equity 500% %
Return On Equity -1401% % -4431%
Return On Assets -214% % -176%
Operating Margin -20141% % -5548%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 10,664,064 shares 20%
Common Stock, Shares, Outstanding 10,543,000 shares 19%
Entity Public Float $38,400,000 USD 105%
Common Stock, Value, Issued $1,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 10,339,000 shares 17%
Weighted Average Number of Shares Outstanding, Diluted 10,339,000 shares -3.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $116,000 USD -96%
Research and Development Expense $12,119,000 USD 101%
General and Administrative Expense $11,361,000 USD 35%
Operating Income (Loss) $23,364,000 USD -108%
Nonoperating Income (Expense) $4,733,000 USD 23%
Net Income (Loss) Attributable to Parent $18,586,000 USD -153%
Earnings Per Share, Basic 1 USD/shares -381%
Earnings Per Share, Diluted 1 USD/shares -446%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $8,620,000 USD 171%
Accounts Receivable, after Allowance for Credit Loss, Current $65,000 USD 983%
Other Assets, Current $170,000 USD 19%
Assets, Current $11,497,000 USD 112%
Property, Plant and Equipment, Net $580,000 USD 12%
Operating Lease, Right-of-Use Asset $312,000 USD -39%
Intangible Assets, Net (Excluding Goodwill) $509,000 USD -20%
Assets $12,413,000 USD 67%
Accounts Payable, Current $2,731,000 USD
Accrued Liabilities, Current $1,144,000 USD -1.3%
Liabilities, Current $8,789,000 USD -35%
Operating Lease, Liability, Noncurrent $148,000 USD -53%
Liabilities $10,819,000 USD -49%
Accumulated Other Comprehensive Income (Loss), Net of Tax $4,000 USD
Retained Earnings (Accumulated Deficit) $60,164,000 USD -45%
Stockholders' Equity Attributable to Parent $1,760,000 USD
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $1,594,000 USD
Liabilities and Equity $12,413,000 USD 67%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $4,322,000 USD -174%
Net Cash Provided by (Used in) Financing Activities $4,917,000 USD 80%
Net Cash Provided by (Used in) Investing Activities $0 USD
Common Stock, Shares Authorized 40,000,000 shares 0%
Common Stock, Shares, Issued 10,543,000 shares 19%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $595,000 USD -48%
Interest Paid, Excluding Capitalized Interest, Operating Activities $1,000 USD -93%
Deferred Tax Assets, Valuation Allowance $35,445,000 USD 176%
Deferred Tax Assets, Gross $35,671,000 USD 175%
Operating Lease, Liability $311,000 USD -39%
Depreciation $0 USD
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $4,589,000 USD -425%
Lessee, Operating Lease, Liability, to be Paid $335,000 USD -40%
Property, Plant and Equipment, Gross $1,230,000 USD 26%
Operating Lease, Liability, Current $163,000 USD -17%
Lessee, Operating Lease, Liability, to be Paid, Year Two $117,000 USD -26%
Lessee, Operating Lease, Liability, to be Paid, Year One $159,000 USD -27%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $24,000 USD -52%
Lessee, Operating Lease, Liability, to be Paid, Year Three $10,000 USD -91%
Deferred Tax Assets, Operating Loss Carryforwards $22,465,000 USD 121%
Preferred Stock, Shares Issued 965,000 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $816,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $10,000 USD
Operating Lease, Payments $56,000 USD 1.8%
Additional Paid in Capital $56,987,000 USD 105%
Preferred Stock, Shares Outstanding 965,000 shares
Amortization of Intangible Assets $101,000 USD -23%
Deferred Tax Assets, Net of Valuation Allowance $226,000 USD 61%
Share-based Payment Arrangement, Expense $3,833,000 USD 138%
Interest Expense $4,913,000 USD 72%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%